Respiratory failure & ventilation
Right ventricle-specific therapies in acute respiratory distress syndrome: a scoping review
Authors' conclusion
Given the prevalence of RVD in ARDS and its association with mortality, the dearth of research on this topic is concerning.
Study context
- Population
- Patients with acute respiratory distress syndrome (ARDS) and right ventricular dysfunction (RVD); studies reporting effects of treatments on right ventricular function
- Participants
- 1,526 patients · 51 studies
- Outcome
- Interventions and designs of included studies
Methodological details1,430 studies screened; MEDLINE, Embase, CINAHL, Web of Science, Cochrane Central searched; extraction in duplicate
- 1,430 studies screened; MEDLINE, Embase, CINAHL, Web of Science, Cochrane Central searched; extraction in duplicate
Main finding
As reported in the abstract
- Ventilator settings
- 29.4%
- Inhaled medications
- 33.3%
- Extracorporeal life support
- 13.7%
- IV or oral medications
- 13.7%
- Prone positioning
- 9.8%
- Non-randomized experimental studies
- 53%
- Case reports
- 16%
- RCTs
- 5.9%
- Studies conducted with the goal of modifying RV function
- 27%
Original publication
Right ventricle-specific therapies in acute respiratory distress syndrome: a scoping review. Crit Care. Published 12 March 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →